"ASCEND allows us to reach new markets, including life sciences firms and other research-oriented organizations," said Steve Coy, Executive Director of IMPAQ Strategy. "This technology platform will support collaboration, research, and advanced healthcare analytics to drive discovery of clinical evidence and network healthcare professionals to coordinate large-scale studies."
IMPAQ Strategy will use this acquisition to support its data-driven management consulting practice. The ASCEND Clinical Collaboration Network will bring together ASCEND users for knowledge sharing, networking, and best practices. Health Data Capture Tools will power clinical studies, patient reported outcomes, and post-market surveillance. The Advanced Analytics Engine will blend linked data, analytics, and data visualizations via web and mobile tools to better understand complex clinical data, predict patterns, and conduct quality audits. Finally, the Active Response System will send targeted messaging based on clinical and well-being health information to drive quality improvement, physician guidelines adherence, and patient education.
About IMPAQ Strategy
IMPAQ Strategy helps associations and foundations, hospitals and health systems, medical societies, life sciences, and research organizations increase their influence and advance their missions through innovative thinking, expanded digital reach, advanced analytical platforms, and insightful evaluation.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/impaq-international-launches-ascend-health-intelligence-platform-and-acquires-the-assets-of-europe-based-digital-support-300306967.html
SOURCE IMPAQ Strategy